Alx Oncology Holdings ALXO
NASDAQ ALXO
$1.22 -0.08 (-6.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alx Oncology Holdings (ALXO) Cash from Financing Activities (2019 - 2026)

Updated

Alx Oncology Holdings' Cash from Financing Activities was $137,000 in Q2 2026, compared with -$222,000 a year earlier and down 99.9% from the prior quarter.

Analysis

Alx Oncology Holdings (ALXO) Cash from Financing Activities (2019 - 2026) Analysis & Trends

On a trailing twelve-month basis, Alx Oncology Holdings' Cash from Financing Activities was $140.25 million through Jun 30, 2026; for FY2025, it was $362,000, down 98.8% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -76.1% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $30.82 million in FY2024 (-48.0%), $59.29 million in FY2023 (+501.3%), $9.86 million in FY2022 (+298.9%) and $2.47 million in FY2021 (-99.5%).
  • Quarterly Cash from Financing Activities has moved between -$222,000 (Q2 2025) and $139.6 million (Q1 2026) over five years.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q4 2023 (growth of 523.2%); the worst was Q3 2021 (a decline of 99.7%).
  • Per Business Quant data, ALXO's Cash from Financing Activities in the three quarters before Q2 2026 was $139.6 million (Q1 2026), $678,000 (Q4 2025) and -$159,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 8.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -8.78 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -5.05 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 1.76 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -2.02 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -47.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -1.48 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 2.34 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -3.66 Bn
10 Alx Oncology Holdings 179.68 Mn 179.68 Mn - 137,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 137,000.00
Mar 31, 2026 139.60 Mn
Dec 31, 2025 678,000.00
Sep 30, 2025 -159,000.00
Jun 30, 2025 -222,000.00
Mar 31, 2025 65,000.00
Dec 31, 2024 328,000.00
Sep 30, 2024 251,000.00
Jun 30, 2024 27.15 Mn
Mar 31, 2024 3.09 Mn
Dec 31, 2023 59.17 Mn
Sep 30, 2023 -111,000.00
Jun 30, 2023 343,000.00
Mar 31, 2023 -107,000.00
Dec 31, 2022 9.49 Mn
Sep 30, 2022 -136,000.00
Jun 30, 2022 422,000.00
Mar 31, 2022 80,000.00
Dec 31, 2021 524,000.00
Sep 30, 2021 439,000.00
API Access

Alx Oncology Holdings Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=ALXO&period=max&api_key=YOUR_API_KEY